mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.6 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.6 |